Filing Details

Accession Number:
0001127602-14-032135
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-13 16:27:41
Reporting Period:
2014-11-11
Filing Date:
2014-11-13
Accepted Time:
2014-11-13 16:27:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579873 J. Sarah Schlesinger C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-11 1,300 $6.30 9,100 No 4 P Indirect Spouse
Common Stock Acquisiton 2014-11-12 1,300 $6.22 10,400 No 4 P Indirect Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Spouse
No 4 P Indirect Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,500 Direct
Footnotes
  1. Shares were purchased pursuant to a Rule 10b5-1 trading plan.